Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Pioglitazone in Hepatitis C

NCT00189163

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +20 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

NCT02399345

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV Infection Genotype 1), +15 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

NCT01899092

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: UCSD Antiviral Research Center San Diego, California, United States

Duke Clinical Research Institute Durham, North Carolina, United States

The Liver Institute at Methodist Dallas Dallas, Texas, United States

The Texas Liver Institute San Antonio, Texas, United States

View Trial Details

Completed

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

NCT01285050

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +26 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

NCT01280656

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Rio Branco, Acre, Brazil

Manaus, Amazonas, Brazil

Vitória, Espírito Santo, Brazil

Salvador, Estado de Bahia, Brazil

View all 37 locations

View Trial Details

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

NCT02250807

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Badalona, Spain

Barcelona, Spain

Madrid, Spain

Santander, Spain

View Trial Details

Completed

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

NCT00759200

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Novartis Investigative site Clayton, Australia

Novartis Investigative site Fitzroy, Australia

Novartis Investigative site Greenslopes, Australia

Novartis Investigative site Kingswood, Australia

View all 55 locations

View Trial Details

Completed

A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

NCT00377182

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: La Jolla, California, United States

Long Beach, California, United States

Sacramento, California, United States

San Diego, California, United States

View all 18 locations

View Trial Details

Completed

A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

NCT00940420

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Afula, Israel

Ashkelon, Israel

Bat Yam, Israel

Beersheba, Israel

View all 20 locations

View Trial Details

Completed

A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)

NCT01278134

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: La Jolla, California, United States

Sacramento, California, United States

Orlando, Florida, United States

Marietta, Georgia, United States

View all 32 locations

View Trial Details